Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States food and drug administration

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 272-276

  Kohlroser, James ^a   Mathai, Jijy ^a,b   Reichheld, James ^a,b   Banner, Barbara F ^a,b   Bonkovsky, Herbert L ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Pancreatic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROGLITAZONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DRUG WITHDRAWAL; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

CHROMANS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; LIVER FAILURE; MALE; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0033988825     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00766-2     Document Type: Article

References (11)

1. Henry R.R. Thiazolidinediones. Endocrinol Metab Clin North Am. 26:1997;553-573.
2. Spencer C.M., Markham A. Troglitazone. Drugs. 54:1997;89-102.
3. Prescribing Information for Rezulin. July 1998. Morris Plains, NJ: Parke-Davis.
4. US Food and Drug Administration. Patient testing and labeling strengthened for Rezulin. FDA Talk Paper: T97-61. Dec. 1, 1997. Rockville, MD: US Food and Drug Administration.
5. Gitlin N., Neil J.L., Spurr C.L., et al. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann Intern Med. 129:1998;36-38.
6. Neuschwander-Tetri B.A., Isley W.L., Oki J.C., et al. Troglitazone-induced hepatic failure leading to liver transplantation A case report . Ann Intern Med. 129:1998;38-41.
7. Watkins P.B., Whitcomb R.W. Hepatic dysfunction associated with troglitazone. N Engl J Med. 388:1998;916-917.
8. Imura H. Troglitazone. N Engl J Med. 338:1998;808-809. (editorial).
9. Izumi I., Hosiyama K., Enomoto S., et al. Pharmacokinetics of troglitazone, an antidiabetic agent Prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data . J Pharmacol Exptl Therap. 280:1997;1392-1400.
10. Kawai K., Kawasaki-Tokui Y., Odaka T., et al. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs. Arzneimittel-Forschung. 47:1997;356-368.
11. Yamazaki H., Shibata A., Suzuki M., et al. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab Dispos. 27:1999;1260-1266.